Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05Mind-Body Medicine for Adolescents and Young Adults (AYA) Coping With Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-04Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-04Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of BCL2 Inhibitor BGB-11417 in Adult Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-04Chimeric Antigen Receptor Treatment Targeting Lymphoma, Myeloma and Solid Tumors That Express CD70 (SEventY) CALySSEY
-
CLINICAL_TRIALS study record update · 2026-03-04CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-03-02Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-27Digital Intervention to Promote Physical Activity and Improve Cardiovascular Health Among Cancer Survivors
-
CLINICAL_TRIALS study record update · 2026-02-27A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 2 Study of Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-25Pragmatic Hybrid Type 1 Effectiveness-implementation (E-I) Trial of a Virtual Cancer Rehabilitation Program
-
CLINICAL_TRIALS study record update · 2026-02-24An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2026-02-24Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-20A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-20The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial
-
CLINICAL_TRIALS study record update · 2026-02-20Phase II Study of Pembrolizumab for PD-L1 Gene-Altered, Relapsed/Refractory DLBCL
-
CLINICAL_TRIALS study record update · 2026-02-20A Pilot Study of Pembrolizumab in Combination With Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-19A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-18Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-07: A Phase 1/2 Study of CD22-Specific CAR T Cells for CD22+ Leukemia or Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-18A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-02-18A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase II Study Evaluating the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma